Page last updated: 2024-11-05

n-methylhydroxylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11647
CHEMBL ID144761
MeSH IDM0069729

Synonyms (27)

Synonym
4-04-00-03299 (beilstein handbook reference)
unii-v8920j3l6r
v8920j3l6r ,
hydroxylamine, n-methyl-
ch3nhoh
nci-c60066
brn 1730792
methylhydroxylamine
n-hydroxymethylamine
methanamine, n-hydroxy-
n-methylhydroxylamine ,
NSM ,
CHEMBL144761
n-methyl-hydroxylamine
593-77-1
AKOS006229062
methylhydroxylamine, n-
methylhydroxyamine
methyl hydroxylamine
n-methylhydroxyamine
methyl-hydroxyl-amine
n-methyl hydroxylamine
CPQCSJYYDADLCZ-UHFFFAOYSA-N
n-methylhydroxyl-amine
m-ha
DTXSID10208035
Q18378717

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The toxic potency of three industrially used hydroxylamines was studied in human blood cells in vitro."( Two mechanisms for toxic effects of hydroxylamines in human erythrocytes: involvement of free radicals and risk of potentiation.
Baars, LG; Bisschops, RA; Evelo, CT; Neis, JM; Spooren, AA, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID75124Percent inhibition was measured on Soybean Glutamine synthetase (GS) at 0.5 mM concentration1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
4-N-hydroxy-L-2,4-diaminobutyric acid. A strong inhibitor of glutamine synthetase.
AID425210Protective activity against ischemia/reperfusion-induced increase in macromolecular permeability in po dosed golden hamster cheek pouch administered 30 mins before induction of anesthesia2009Bioorganic & medicinal chemistry, Jun-01, Volume: 17, Issue:11
N-tert-butyl and N-methyl nitrones derived from aromatic aldehydes inhibit macromolecular permeability increase induced by ischemia/reperfusion in hamsters.
AID74981Percent inhibition was measured on Sheep Brain Glutamine v (GS) at 0.1 mM concentration1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
4-N-hydroxy-L-2,4-diaminobutyric acid. A strong inhibitor of glutamine synthetase.
AID74976Percent inhibition was measured on Sheep Brain Glutamine synthetase (GS) at 0.2 mM concentration1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
4-N-hydroxy-L-2,4-diaminobutyric acid. A strong inhibitor of glutamine synthetase.
AID425213Protective activity against histamine-induced increase in macromolecular permeability in po dosed golden hamster cheek pouch administered 30 mins before induction of anesthesia2009Bioorganic & medicinal chemistry, Jun-01, Volume: 17, Issue:11
N-tert-butyl and N-methyl nitrones derived from aromatic aldehydes inhibit macromolecular permeability increase induced by ischemia/reperfusion in hamsters.
AID74993Percent inhibition was measured on Soybean Glutamine synthetase (GS) at 0.1 mM concentration1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
4-N-hydroxy-L-2,4-diaminobutyric acid. A strong inhibitor of glutamine synthetase.
AID425211Protective activity against ischemia/reperfusion-induced increase in macromolecular permeability in iv dosed golden hamster cheek pouch administered 10 mins before onset of reperfusion2009Bioorganic & medicinal chemistry, Jun-01, Volume: 17, Issue:11
N-tert-butyl and N-methyl nitrones derived from aromatic aldehydes inhibit macromolecular permeability increase induced by ischemia/reperfusion in hamsters.
AID74994Percent inhibition was measured on Soybean Glutamine synthetase (GS) at 0.2 mM concentration1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
4-N-hydroxy-L-2,4-diaminobutyric acid. A strong inhibitor of glutamine synthetase.
AID74977Percent inhibition was measured on Sheep Brain Glutamine synthetase (GS) at 0.5 mM concentration1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
4-N-hydroxy-L-2,4-diaminobutyric acid. A strong inhibitor of glutamine synthetase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (20.83)18.7374
1990's9 (37.50)18.2507
2000's6 (25.00)29.6817
2010's4 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.03 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index52.06 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]